2006, Number 2
<< Back Next >>
Rev Mex Oftalmol 2006; 80 (2)
Prevalencia de demodecosis en pacientes con blefaroconjuntivitis crónica multitratada
Chin-Wong JL, Niño-Pecina A, Ruiz-Quintero N, Naranjo-Tackman R
Language: Spanish
References: 17
Page: 61-63
PDF size: 38.58 Kb.
ABSTRACT
Objective: To determine the prevalence of Demodex mites in patients with symptomatic multitreated chronic blepharoconjunctivitis and their clinical spectrum.
Methods: A retrospective, observational and descriptive study was performed. Patients with diagnosis of chronic blepharoconjunctivitis which received previous empiric treatment without symptomatic improvement were included. All patients had eyelash direct test and microbiological conjunctival secretion cultures.
Results: 302 patients were included. 176 (58.27%) were positive to Demodex, average age was 52.9 years with a range between 15 and 86 years. More frequent symptoms were: itching (73.86%), conjunctival discharge (64.77%), foreign body sensation (54.54%), red eye (47.72%) and epiphora (36.36%). More frequent signs were: lid margin thickening (94.31%), Meibomian glands dysfunction (86.36%), keratitis sicca (17.04%), madarosis (7.94%) and lid margin telangiectasia (6.81%).
Conclusion: Prevalence of Demodex folliculorum in patients with chronic multitreated blepharoconjunctivitis is similar to the prevalence of the same mite in patients with chronic blepharitis without previous empiric treatment.
REFERENCES
English FP, Zhang GW, McManus DP, Horne FA. The presence of the parasite Demodex folliculorum on the skin surface of the eyelid. Aust N Z J Ophthalmol 1991; 19(3):229-34.
Pena GP, Andrade JS. Is demodex really non-pathogenic? Rev Inst Med Trop Sao Paulo 2000; 42(3):171-3.
English FP, Iwamoto T, Darrell RW, Devoe AG. The vector potential of Demodex folliculorum. Arch Ophthalmol 1970; 84:83-85.
Humiczewska M. Demodex folliculorum and Demodex brevis (Acarida) as the factors of chronic marginal blepharitis. Wiad Parazytol 1991; 37(1):127-30.
Tisma VS, Basta-Juzbasic A, Dobric I. Etiopathogenesis, classification and current trends in treatment of rosacea. Acta Dermatolovenerol Croat 2003; 11(4):236-46.
Morras PG, Santos SP, Imedio IL, Echeverria ML. Rosacealike demodicidosis in an immunocompromised child. Pediatr Dermatol. 2003; 20(1):28-30.
Pecorella I, Ciardi A, Maedsco A, Di Tondo U. Histological findings in the eyelids of AIDS patients. Acta Ophthalmol Scand 1999; 77(5):564-7.
Damian D, Rogers M. Demodex infestation in a child with leukaemia: treatment with ivermectin and permethrin. Int J Dermatol 2003; 42(9):724-6.
Norn MS. Demodex folliculorum. Incidence and possible pathogenic role in the human eyelid. Acta Ophthalmol 1970; 71:938.
Hussein N, Schwab I, Ostler B. Blepharitis. En: Duane’s clinical ophthalmology CD-ROM (Vol 4); Lippincott Williams & Wilkins. 2003.
Gamboa J, Cortés M, Rodriguez A. Incidencia de Demodex folliculorum en blefaritis. Rev Mex Oftalmol 2003; 77(2).
Nava A, Tovilla J, Muñoz S. Prevalencia de Demodex folliculorum en pacientes con blefaritis crónica. Rev Mex Oftalm 2001; 75(4):140-144.
Demmler M, de Kaspar HM, Mohring C, Klauss V. Blepharitis. Demodex folliculorum, associated pathogen spectrum and specific therapy. Ophthalmologe 1997; 94(3):191-6.
Fulk GW, Murphy B, Robins MD. Pilocarpine gel for the treatment of demodicosis -a case series. Optom Vis Sci 1996; 73(12):742-5.
El-Shazly AM, Hassan AA, Soliman M, Morsy GH. Treatment of human Demodex folliculorum by camphor oil and metronidazole. J Egypt Soc Parasitol 2004; 34(1):107-16.
Swenor ME. Is permethrin 5% cream effective for rosacea? J Fam Pract 2003; 52(3):183-4.
Huismans H. Demodex folliculorum. Klin Monatsbl Augenheilkd 1988; 193(3):304-6.